Skip to Main Content

Paper Details

Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease.
Ann Intern Med
0
2022
Author NameAffiliation
Elisabetta PatornoBrigham and Women's Hospital and Harvard Medical School
Sebastian SchneeweissBrigham and Women's Hospital and Harvard Medical School
  • 1 - 2

Datasets

Release 1.2